Published in Biomaterials on January 20, 2009
Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials (2009) 1.23
Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition. Acta Biomater (2012) 1.16
Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials (2011) 1.06
Extracellular matrix-mimetic adhesive biomaterials for bone repair. J Biomed Mater Res A (2010) 0.99
Emerging techniques in stratified designs and continuous gradients for tissue engineering of interfaces. Ann Biomed Eng (2010) 0.97
Review collagen-based biomaterials for wound healing. Biopolymers (2014) 0.93
Role of cell-matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels. J Tissue Eng Regen Med (2013) 0.93
Effective combination of aligned nanocomposite nanofibers and human unrestricted somatic stem cells for bone tissue engineering. Acta Pharmacol Sin (2011) 0.91
Detection of osteogenic differentiation by differential mineralized matrix production in mesenchymal stromal cells by Raman spectroscopy. PLoS One (2013) 0.91
Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain. Biomaterials (2010) 0.91
Emerging concepts in engineering extracellular matrix variants for directing cell phenotype. Regen Med (2009) 0.88
Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C. J Biol Chem (2010) 0.86
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone. Biomaterials (2012) 0.85
Hydroxyapatite nanoparticle reinforced peptide amphiphile nanomatrix enhances the osteogenic differentiation of mesenchymal stem cells by compositional ratios. Acta Biomater (2012) 0.83
The enhanced effect of surface microstructured porous titanium on adhesion and osteoblastic differentiation of mesenchymal stem cells. J Mater Sci Mater Med (2013) 0.79
Osteoinduction by Ca-P biomaterials implanted into the muscles of mice. J Zhejiang Univ Sci B (2011) 0.79
Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains. J Biomed Mater Res A (2013) 0.79
The collagen I mimetic peptide DGEA enhances an osteogenic phenotype in mesenchymal stem cells when presented from cell-encapsulating hydrogels. J Biomed Mater Res A (2015) 0.78
Carbonate hydroxyapatite functionalization: a comparative study towards (bio)molecules fixation. Interface Focus (2014) 0.77
Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials. Int J Oral Maxillofac Implants (2014) 0.77
Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials. Tissue Eng Part A (2015) 0.76
rFN/Cad-11-modified collagen type II biomimetic interface promotes the adhesion and chondrogenic differentiation of mesenchymal stem cells. Tissue Eng Part A (2013) 0.76
The role of peptides in bone healing and regeneration: a systematic review. BMC Med (2016) 0.75
Carbon Nanostructures in Bone Tissue Engineering. Open Orthop J (2016) 0.75
PEG-peptide hydrogels reveal differential effects of matrix microenvironmental cues on melanoma drug sensitivity. Integr Biol (Camb) (2017) 0.75
P15 peptide stimulates chondrogenic commitment and endochondral ossification. Int Orthop (2017) 0.75
Specific biofunctional performances of the hydroxyapatite-sodium maleate copolymer hybrid coating nanostructures evaluated by in vitro studies. J Mater Sci Mater Med (2009) 0.75
The use of bioactive peptides to modify materials for bone tissue repair. Regen Biomater (2017) 0.75
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem (1997) 6.30
Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J (1986) 3.54
Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A (1983) 2.97
Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng (2005) 2.82
The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem (2000) 2.56
Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem (1998) 2.26
Physiology of fibronectin. Annu Rev Med (1984) 2.17
Structure and biological role of vitronectin. Annu Rev Cell Biol (1991) 2.02
Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem (1989) 2.00
Adhesion to Vitronectin and Collagen I Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells. J Biomed Biotechnol (2004) 1.88
Blood coagulation. Lancet (2000) 1.84
Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem (1991) 1.79
A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell (1993) 1.75
Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem (1997) 1.66
Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction. J Cell Physiol (2000) 1.59
Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem (1997) 1.51
Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem (1998) 1.51
The RGD story: a personal account. Matrix Biol (2003) 1.47
Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem (2001) 1.46
Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res (2005) 1.41
Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials (2007) 1.37
Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem (1991) 1.33
Structure of the integrin alpha2beta1-binding collagen peptide. J Mol Biol (2004) 1.30
The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials (2008) 1.26
Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res (2001) 1.23
Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem (2000) 1.22
Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A (2004) 1.20
The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials (2006) 1.15
Suppression of apoptosis by enhanced protein adsorption on polymer/hydroxyapatite composite scaffolds. Biomaterials (2007) 1.14
Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results. J Periodontol (1998) 1.13
Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. J Biomed Mater Res A (2003) 1.11
Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone (2001) 1.10
Regulation of mesenchymal stem cell attachment and spreading on hydroxyapatite by RGD peptides and adsorbed serum proteins. Biomaterials (2005) 1.04
Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci Mater Med (2004) 1.03
The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1 (I) chain: structural and biological evidence for conformational tautomerism on fiber surface. J Biomol Struct Dyn (1997) 1.02
Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res (2002) 1.01
Development of specific collagen scaffolds to support the osteogenic and chondrogenic differentiation of human bone marrow stromal cells. Biomaterials (2008) 1.01
Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng (1999) 1.00
Phenotypic expression of bone-related genes in osteoblasts grown on calcium phosphate ceramics with different phase compositions. Biomaterials (2004) 1.00
Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol (2000) 0.99
Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite. J Biomed Mater Res A (2004) 0.99
Three-dimensional culture of differentiating marrow stromal osteoblasts in biomimetic poly(propylene fumarate-co-ethylene glycol)-based macroporous hydrogels. J Biomed Mater Res A (2003) 0.98
Biomimetic peptides that engage specific integrin-dependent signaling pathways and bind to calcium phosphate surfaces. J Biomed Mater Res A (2003) 0.97
Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J Cell Sci (1995) 0.96
Diverse mechanisms of osteoblast spreading on hydroxyapatite and titanium. Biomaterials (2000) 0.94
Quantitative kinetic analysis of gene expression during human osteoblastic adhesion on orthopaedic materials. Biomaterials (2006) 0.92
Electrospun fibrous web of collagen-apatite precipitated nanocomposite for bone regeneration. J Mater Sci Mater Med (2008) 0.90
Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression. Matrix Biol (2003) 0.87
Additive effect of RGD coating to functionalized titanium surfaces on human osteoprogenitor cell adhesion and spreading. Tissue Eng Part A (2008) 0.85
Periodontal regeneration following use of ABM/P-1 5: a case report. Int J Periodontics Restorative Dent (2002) 0.85
Biomimetic surfaces for control of cell adhesion to facilitate bone formation. Crit Rev Eukaryot Gene Expr (2002) 0.83
Anorganic bovine matrix/p-15 "flow" in the treatment of periodontal defects: case series with 12 months of follow-up. J Periodontol (2006) 0.83
A comparison of ProOsteon, DBX, and collagraft in a rabbit model. J Biomed Mater Res B Appl Biomater (2006) 0.82
Evaluation of suitable biodegradable scaffolds for engineered bone tissue. Med J Malaysia (2004) 0.82
Treatment of hydroxyapatite scaffolds with fibronectin and fetal calf serum increases osteoblast adhesion and proliferation in vitro. Plast Reconstr Surg (2008) 0.81
Hydroxyapatite grown on a native extracellular matrix: initial interactions with human fibroblasts. Langmuir (2007) 0.81
Comparative clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and open flap debridement (DEBR) in human periodontal osseous defects: a 6 month pilot study. J Int Acad Periodontol (2004) 0.80
Comparison of bone grafting materials in human extraction sockets: clinical, histologic, and histomorphometric evaluations. Implant Dent (2006) 0.79
A new method for analysis of the adsorbed plasma protein layer on biomaterial surfaces. Trans Am Soc Artif Intern Organs (1976) 0.79
Fibronectin preadsorbed on hydroxyapatite together with rough surface structure increases osteoblasts' adhesion "in vitro": the theoretical usefulness of fibronectin preadsorption on hydroxyapatite to increase permanent stability and longevity in spine implants. J Spinal Disord Tech (2005) 0.79
Specific activation of platelets by surface-adsorbed plasma proteins. J Biomater Sci Polym Ed (1998) 0.78
Clinical, radiographic, histologic, and histomorphometric comparison of PepGen P-15 particulate and PepGen P-15 flow in extraction sockets: a same-mouth case study. Implant Dent (2003) 0.78
A comparative evaluation of the effectiveness of an anorganic bone matrix/cell binding peptide with an open flap debridement in human infrabony defects: a clinical and radiographic study. J Contemp Dent Pract (2007) 0.78
Maxillary sinus augmentation using a synthetic cell-binding peptide: a histologic and transmission electron microscopy case study in man. Implant Dent (2005) 0.76
Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res (2005) 2.08
Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone. Biomaterials (2013) 1.47
Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem (2008) 1.40
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells (2008) 1.37
Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev (2012) 1.32
ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res (2008) 1.26
The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials (2008) 1.26
Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem (2002) 1.25
Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem (2010) 1.23
Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem (2011) 1.19
Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation. J Biol Chem (2007) 1.18
A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. J Biol Chem (2005) 1.15
The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials (2006) 1.15
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Res (2013) 1.15
Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma. Clin Cancer Res (2013) 1.13
Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials (2011) 1.11
Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins. J Biol Chem (2008) 1.09
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp Cell Res (2008) 1.09
Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite. PLoS One (2011) 1.05
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules (2009) 1.04
Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide. Biomaterials (2005) 1.04
An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold. Biomaterials (2010) 1.03
ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor. J Biol Chem (2011) 0.99
Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite. J Biomed Mater Res A (2004) 0.99
Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev (2009) 0.99
Low temperature induces the delivery of mature and immature CFTR to the plasma membrane. Biochem Biophys Res Commun (2007) 0.98
Reversible on-demand cell alignment using reconfigurable microtopography. Biomaterials (2008) 0.97
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. J Ovarian Res (2013) 0.95
Mesenchymal stem cell interaction with ultra-smooth nanostructured diamond for wear-resistant orthopaedic implants. Biomaterials (2008) 0.94
Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One (2012) 0.94
Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells. J Biomed Mater Res A (2011) 0.92
Effect of altered glycosylation on the structure of the I-like domain of beta1 integrin: a molecular dynamics study. Proteins (2008) 0.91
Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain. Biomaterials (2010) 0.91
Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration. Tissue Eng Part A (2014) 0.87
In vivo performance of bilayer hydroxyapatite scaffolds for bone tissue regeneration in the rabbit radius. J Mater Sci Mater Med (2011) 0.86
Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy. J Biomed Mater Res A (2006) 0.86
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone. Biomaterials (2012) 0.85
Working group report: the roles of glycans in hemostasis, inflammation and vascular biology. Glycobiology (2008) 0.84
Preliminary tribological evaluation of nanostructured diamond coatings against ultra-high molecular weight polyethylene. J Biomed Mater Res B Appl Biomater (2008) 0.84
Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials. J Nanosci Nanotechnol (2004) 0.82
Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite. J Mater Sci Mater Med (2008) 0.81
Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains. J Biomed Mater Res A (2013) 0.79
Novel naturally crosslinked electrospun nanofibrous chitosan mats for guided bone regeneration membranes: material characterization and cytocompatibility. J Tissue Eng Regen Med (2012) 0.77
Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials. Int J Oral Maxillofac Implants (2014) 0.77
Autologous Minced Muscle Grafts Improve Muscle Strength in a Porcine Model of Volumetric Muscle Loss Injury. J Orthop Trauma (2016) 0.76
Enhanced Skin Regeneration Using a Novel Amniotic-derived Tissue Graft. Wounds (2017) 0.75